Taclonex and Soriatane drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Taclonex (betamethasone dipropionate; calcipotriene hydrate) and Soriatane (acitretin). Common drug interactions include pain among females and erythrodermic psoriasis among males.

The phase IV clinical study analyzes what interactions people have when they take Taclonex and Soriatane. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Taclonex?

Taclonex has active ingredients of betamethasone dipropionate; calcipotriene hydrate. It is often used in psoriasis. eHealthMe is studying from 1,618 Taclonex users. Check the latest studies of Taclonex.

What is Soriatane?

Soriatane has active ingredients of acitretin. It is often used in psoriasis. eHealthMe is studying from 3,834 Soriatane users. Check the latest studies of Soriatane.



On Apr, 09, 2026

29 people who take Taclonex and Soriatane together, and have interactions are studied.

Taclonex and Soriatane drug interactions.

What are the common drug interactions of Taclonex and Soriatane, by gender? *:

female:

  1. Pain
  2. Headache (pain in head)
  3. Nausea (feeling of having an urge to vomit)
  4. Colon cancer
  5. Diarrhoea
  6. Erythema (redness of the skin)
  7. Gait disturbance
  8. Guttate psoriasis (a type of psoriasis that looks like small drops on the skin)
  9. Hepatic enzyme increased
  10. Sebaceous hyperplasia (a disorder of the sebaceous glands in which they become enlarged)

male:

  1. Erythrodermic psoriasis (generalized redness of the skin)
  2. Hyperkeratosis (thickening of the outer layer of the skin)
  3. Multiple drug overdose
  4. Osteonecrosis (death of bone)
  5. Renal impairment (severely reduced kidney function)
  6. Suicide attempt
  7. Drug effect decreased
  8. Headache (pain in head)
  9. Joint effusion (presence of extra fluid in joint covering)
  10. Joint stiffness

What are the common drug interactions of Taclonex and Soriatane, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Multiple drug overdose
  2. Suicide attempt

20-29:

n/a

30-39:

n/a

40-49:

  1. Headache (pain in head)
  2. Osteonecrosis (death of bone)
  3. Abdominal pain upper
  4. Acne (skin problems that cause pimples)
  5. Activities of daily living impaired
  6. Alopecia (absence of hair from areas of the body)
  7. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  8. Arthralgia (joint pain)
  9. Diarrhoea
  10. Dry skin

50-59:

  1. Chronic kidney disease
  2. Colon cancer
  3. Guttate psoriasis (a type of psoriasis that looks like small drops on the skin)
  4. Renal impairment (severely reduced kidney function)
  5. Sebaceous hyperplasia (a disorder of the sebaceous glands in which they become enlarged)
  6. Arthralgia (joint pain)
  7. Back pain
  8. Blood urine present
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)

60+:

  1. Erythrodermic psoriasis (generalized redness of the skin)
  2. Hyperkeratosis (thickening of the outer layer of the skin)
  3. Balance disorder
  4. Chest pain
  5. Chronic kidney disease
  6. Dementia (madness)
  7. Drug effect decreased
  8. Drug ineffective
  9. Erythema (redness of the skin)
  10. Eye pain

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 17.24%
  2. Pain: 3 people, 10.34%
  3. Infection: 2 people, 6.90%
  4. High Blood Pressure: 2 people, 6.90%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.90%
  6. Erection Problems: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Taclonex and Soriatane?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Taclonex and Soriatane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Taclonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Soriatane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Taclonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soriatane and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone dipropionate; calcipotriene hydrate and acitretin (the active ingredients of Taclonex and Soriatane, respectively), and Taclonex and Soriatane (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: